← All FDA warning letters

FDA Warning Letter · #706335

Wwwbuynetmedscom — FDA Warning Letter (June 12, 2025)

Issued June 12, 2025Status: activeCenter for Drug Evaluation and Research (CDER)

In plain English

FDA warning letter

FDA issued this warning letter to Wwwbuynetmedscom. It turns up in FDA’s warning-letter search for semaglutide. We don’t hold the letter’s text, so the specific violations are on fda.gov.

What it means for you

Read the letter before buying from this seller. Get GLP-1s only with a prescription, filled by a state-licensed pharmacy.

Drugs named:semaglutide

Primary Source

View the original FDA letter on fda.gov →

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/wwwbuynetmedscom-706335-06122025

Letter details

Company
Wwwbuynetmedscom
Letter number
#706335
Issue date
June 12, 2025

What FDA warning letters mean

A warning letter is FDA's principal means of telling a company that the agency considers something it's doing — a marketing claim, a manufacturing practice, a labeling choice — to violate the Federal Food, Drug, and Cosmetic Act. Companies typically have 15 working days to respond.

A warning letter is not a recall, a criminal charge, or a finding that the company has broken the law. It is the start of a regulatory conversation. FDA may issue a close-out letter once it is satisfied that the company has corrected the cited issues.

For compounded GLP-1 telehealth providers, the most common citations involve unapproved new drug claims, misbranding, and the use of bulk drug substances not on FDA's approved list under FDCA sections 503A and 503B.

What this letter means if you use compounded GLP-1s

A warning letter is not a recall, and it does not by itself mean a product you already have is unsafe, but it does mean the FDA found problems it expects Wwwbuynetmedscom to fix. Compounded GLP-1s are not FDA-approved, and the rules for selling them changed when the shortages ended; our explainer on where compounded semaglutide stands with the FDA now covers what is still allowed.

We hold only the basic record for this letter, so check any seller yourself before ordering. You can run a pharmacy through our pharmacy legitimacy lookup, and the semaglutide reference page names the FDA-approved brands.

Other warning letters in our database

View the full database →

Editorial Disclaimer

FDA warning letters are public regulatory communications and do not, on their own, indicate that a company has done anything illegal. Companies often respond to warning letters with corrective action, and many letters are eventually closed out. The full text of this letter is available on fda.gov via the link above.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.